ADAPTIVE BIOTECHNOLOGIES CORPORATION: cashflow_investing

Value{"amount": 181210000, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities", "currency": "USD"}
Period2021-01-01 – 2021-12-31
Statuscurrent
EntityADAPTIVE BIOTECHNOLOGIES CORPORATION
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001564590-22-005228
Retrieved: 2026-08-19T14:40:41.432875+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001478320/cashflow-investing/2021-12-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/d12766e0-1131-4b5d-9ae4-4b1043d255fc

History